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DOI 10.1016/j.stem.2011.12.005In their recent article entitled ‘‘Large-Scale
Analysis Reveals Acquisition of Lineage-
Specific Chromosomal Aberrations in
Human Adult Stem Cells,’’ Ben-David
andcolleagues conclude that humanadult
mesenchymal stromal cells (MSCs) have
a 4% probability of acquiring chromo-
somal abnormalities (Ben-David et al.,
2011). Moreover, the authors propose,
based on their analysis, that transplanta-
tion of adult stem cells may result in tumor
formation, an assertion that calls into
question the safety of MSC-based cell
therapy. Their study isbasedonacompre-
hensive evaluation of acquired chromo-
somal aberrations performed using gene
expression profiles for a large series of
human stem cells from different origins
(neural stem cells, MSCs, and pluripotent
stem cells). However, in our opinion some
of the points within the reported results
and in the presented conclusions should
have been discussed in a more balanced
way, particularly those that relate to adult
MSCs, which are already being used for
clinical trials looking at immunoregulation
and tissue repair.
Overall, Ben-David et al. identified
MSC genetic instability in 4 studies out
of the 22 that they analyzed. In one
of them (GSE18934_GSM469130; Ben-
David et al.’s Table S1), the MSCs pre-
senting chromosomal aberrations were
derived from fetal liver, and thus should
not be considered postnatal stem cells
of adult origin. In another (GSE9520;
Ben-David et al.’s Table S1), Ben-David
et al. report three different MSC prepara-
tions displaying the same monosomy 6qappearing at the beginning of the second
passage at day 2, but later disappearing
at day 7. This culture development is not
discussed by Ben-David et al., but would
seem to be at odds with their general in-
terpretation that ‘‘in MSCs chromosomal
aberrations can take over the culture in
as few as seven passages’’ and that ‘‘mul-
tipotent stem cells are prone to acquire
advantageous chromosomal aberrations
that enable them to rapidly outgrow the
normal cell population.’’ On the contrary,
these results suggest a selective pressure
against monosomy 6q. The findings of
Ben-David et al. that only 4% of examined
MSC lines carry a detectable genomic
abnormality is in agreement with those
of Tarte et al. (2010), who reported a longi-
tudinal study of 20 clinical-grade MSC
preparations obtained using two distinct
and well-defined culture conditions and
showed that the cells do display some
chromosomal abnormalities, i.e. trisomies
of chromosomes 5, 8, and/or 20, as de-
tected using conventional karyotype and
FISH analysis. However, as for the mono-
somy 6q, these trisomies did not appear
to confer any selective mitogenic advan-
tage in vitro and disappeared rapidly after
the second or the third passage. Finally,
all MSC batches reached senescence
without recurrence of these chromosomal
abnormalities and no cell transformation
could be documented either in vitro or in
immunocompromised mice. All these ob-
servations argue against the idea that
acquisition of lineage-specific chromoso-
mal aberrations confers a growth advan-
tage in human adult stem cells.Cell Stem CelFinally, Ben-David et al. cite certain
potentially misleading articles to support
their arguments. The potential transfor-
mation of MSCs in culture reported by
Røsland et al. (2009) was related to a
cross-contamination by various cancer
cell lines (Torsvik et al., 2010). The same
problem occurred in a study performed
on adipose tissue-derived MSCs that
was subsequently retracted (de la Fuente
et al., 2010, addressed by Garcia et al.,
2010), underlining the absolute require-
ment to validate, prior to scientific publi-
cation, that the cells analyzed at the end
of a culture period actually derive from
those used to initiate the culture. It also
seems misleading to state that ‘‘trans-
plantation of human adult stem cells
may result in tumor formation’’ by refer-
encing an article in which cells used
were fetal neural cells and not adult
cells (Amariglio et al., 2009), and another
article showing tumor formation only in
immunocompromised mice injected with
NSCs derived from an olfactory bulb adja-
cent to meningioma (Casalbore et al.,
2009).
In conclusion, we would argue that
genomic stability of cultured adult stem
cells and MSCs in particular is robust
and not as significant a source of concern
as was suggested by Ben-David et al.
(2011). Thus, we would suggest that a
more balanced view of the fundamental
issue of genetic stability of adult stem
cells should be provided to all parties
with an interest in this field, including
researchers, physicians, and regulatory
authorities.l 10, January 6, 2012 ª2012 Elsevier Inc. 9
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DOI 10.1016/j.stem.2011.12.007Our recent article (Ben-David et al., 2011)
presented a comprehensive evaluation of
chromosomal aberrations in pluripotent
and multipotent cell types. We reported
that 9% of the pluripotent and neural
stem cells (PSCs andNSCs, respectively),
and 4% of the mesenchymal stem cells
(MSCs), that we analyzed harbored large
chromosomal aberrations. We found that
each stem cell type was prone to acquire
distinct recurrent chromosomal abnor-
malities, aberrant cells could outgrow
the normal cells in culture within several
passages, and the common aberrations
in stem cell cultures resembled charac-
teristic aberrations of tumors from the
same cell lineages. Importantly, we de-
tected some aberrations that had been
overlooked—and, consequently, not con-
trolled for—in the original studies report-
ing the cell lines. We therefore concluded
that the genomic integrity of stem cells
should be monitored carefully before
using the cells in a clinical setting. We
anticipated that this article would provoke
discussion, and we welcome the ques-
tions raised by Sensebe´ et al. (2012).
First,wewould like to clarify terminolog-
ical ambiguity. In order to distinguish them
from embryonic stem cells (ESCs), we
used the generic terms ‘‘adult stem cells’’
and ‘‘multipotent stem cells’’ alternately,as commonly used to refer to stem cells
derived from adult, newborn, or fetal
tissues, all of which are cell sources
under evaluation for clinical application.
In order to prevent potential confusion,
the exact origin of all MSC samples
analyzed was mentioned throughout the
article. Importantly, seven out of the eight
MSC samples that harbored chromo-
somal aberrations had been derived from
adult tissues (Table S1 in Ben-David
et al., 2011). Moreover, the same aberra-
tion found in the fetal-liver-derived MSC
line (GSE18934_GSM469130) was inde-
pendently identified in an adult-bone-
marrow-derived MSC line (GSE6460_
GSM148485). Therefore, the chromo-
somal aberrationswe identifiedare shared
by MSCs of various origins.
Sensebe´ et al. discuss the observations
by us and others that some chromosomal
aberrations do not confer any growth
advantage to the cells in vitro. However,
such findings do not preclude other
aberrations from being advantageous, as
we found in the caseof aberrations in chro-
mosomes 7q and 17q, which appeared in
a bone-marrow-derived MSC line by
passage 21 and took over the culture by
passage 28 (GSE7637_GSM184649-53).
Moreover, in the case of monosomy 6q,
the aberration did not simply disappearfrom culture; rather, our analysis shows
that it most likely still existed at the later
passage, but didn’t meet the stringent
criteria for statistical significance, probably
due to mosaicism in culture. Because this
monosomy was independently identified
twice in our analysis (Table S1 in Ben-
David et al., 2011), and was also found to
recur in late passages of adipose-tissue-
derived MSCs (Buyanovskaya et al.,
2009), we do not think it should be dis-
missed. Together, these findings are in
line with recent studies of PSCs demon-
strating two types of genomic aberrations:
transient aberrations that occasionally
appear in culture, but are disadvanta-
geous, and thus disappear throughout
culture propagation (Hussein et al., 2011);
and advantageous recurrent aberrations,
which rapidly accumulate in culture in
a clonal manner (Amps et al., 2011; May-
shar et al., 2010). In MSCs, Sensebe´ et al.
discuss the former type; however, the latter
type was also reported by us and others
(Buyanovskaya et al., 2009; Estrada et al.,
2011; Ueyama et al., 2011). Thus, these
two manifestations of genomic instability
exist simultaneously in stem cell cultures.
In this context, it is important to point
out our finding that independent MSC
lines of different origins lost one copy of
chromosome 13. This monosomy was
